Tempest Therapeutics Inc. sell shadow
Start price
12.07.21
/
0%
€32.42
Target price
12.07.22
-
Performance (%)
-92.41%
End price
13.07.22
€2.46
Summary
This prediction ended on 13.07.22 with a price of €2.46. shadow correctly predicted massive losses of -92.41% for Tempest Therapeutics Inc.. This prediction was marked as speculative and is excluded from shadow's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Tempest Therapeutics Inc. | 1.851% | 1.851% | 50.566% |
| iShares Core DAX® | 2.112% | -0.367% | 13.466% |
| iShares Nasdaq 100 | -2.197% | -3.794% | 38.426% |
| iShares Nikkei 225® | -1.555% | -7.320% | 18.451% |
| iShares S&P 500 | -0.472% | -2.078% | 27.488% |
According to shadow what are the pros and cons of Tempest Therapeutics Inc. for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Low dividend yield expected
negative Cash Flow expected
Bad rating
Little Investments for future growth
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Below average Management
Bad culture
Little innovation
Few uniques
Dependend from some customers or products
Growths slower than the competition
Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
Significant cyclical dependencies
Little known brand
Business model of the past or high risk
Comments by shadow for this prediction
In the thread Tempest Therapeutics Inc. diskutieren
Sell Tempest Therapeutics Inc.
In the thread Trading Tempest Therapeutics Inc.
Die von shadow gewählte maximale Laufzeit wurde überschritten